News Center

Home page

Peak Report

News reports

Experience of year-end chat in Jinhua, a pharmaceutical sales company

Release time:

2021-01-21

Pharmaceutical Sales Company Jinhua Office Year-end Chat Experience

Editor's Note:# At the end of the year and the beginning of the year, the Jinhua Office of Pharmaceutical Sales Company organized the salesman to write an annual summary, talk about one year's work and share experiences. This newspaper has excerpted some of them.

Chen Yanguo

Looking back on the past year, I couldn't help feeling deeply touched. There was no vigorous success, but it was also an extraordinary test and sharpening.

2020

was a tough year, from the beginning of the year when the Paroxetine national collection dropped the mark, the new crown epidemic caused the work not to be carried out well until the second quarter to really get to work. However, 2020 is also a brilliant year. My Jinhua Office has completed all sales tasks with everyone's efforts. My personal sales have also increased compared with last year.

Sales is actually a process, including preparation before the visit, visit, and follow-up after the visit. The work of our medical representatives is not like ordinary sales. After the first sales transaction, we have to achieve long-term cooperation, from the first drug to the second-line drug, conventional drug or even recommended drug. Therefore, the follow-up work after our visit has become the focus of our daily work. I feel that in the future follow-up, I should focus on strengthening friendship and building trust, and strive to establish a lasting partnership. Timely follow-up, uninterrupted follow-up visits, let the doctor feel their dedication and respect for him.

At the same time, as a medical representative, we are dealing with highly educated doctors with extensive clinical experience. Therefore, we must continue to learn, improve our professionalism, and create a peer-to-peer platform to communicate with customers.

Shao Junli

Time passed quickly. In a twinkling of an eye, 2020 has passed. In this year, with the support and help of the company's leaders and office managers, combined with my own efforts, I have achieved relatively good results in my work.

I would like to mention again the work done when olopatadine eye drops entered Lanxi Hospital of Traditional Chinese Medicine. Olopatadine Eye Drops is a product for the treatment of allergic conjunctivitis and a blockbuster product of the Pharmaceutical Company in 2020. In July, I greeted the ophthalmologist of the hospital and hoped to help make a report. Because the company's glass eye has been sold in the hospital of traditional Chinese medicine, all the doctors in the ophthalmology department and I have kept visiting frequently, and everyone has great trust in our company's products. At the end of September, Olo was able to enter the hospital. I went to the director of the pharmacy building and showed her our product brochure to tell her the advantages of our products, but the director of the pharmacy department rejected it on the grounds that the price was too high and was unable to enter the hospital. However, I did not give up. Through repeated efforts, the director of the building was finally moved by my sincerity and agreed to go to Tseolo. After a month and a half, I finally successfully developed Olo into Lanxi Hospital of Traditional Chinese Medicine. After this incident, I also realized that as long as the effort is deep, any difficulty can be overcome, and we must have the spirit of perseverance to do a thing successfully.

In the face of the increase or decrease of the national collection and medical insurance catalogue, we medical personnel have gone through tests again and again, but we must face the difficulties. Because we always have to face the difficulties first before we can ride the waves later. We will certainly be able to break through the difficulties, through the winter, ushered in the spring. Looking forward to better 2021.

Zhou Yanqiu

2020

is fleeting. Looking back on this year's work, there are both melancholy and fruitful joy.

2020

is a special year, the new crown epidemic caused by the sudden decline in the foreign population, Yiwu at the beginning of the product catalog adjustment, with volume procurement, three major reasons to the market has brought a considerable impact. I'm a little overwhelmed by the marked decline in market sales. We can't do anything about natural disasters and policies, but the task still needs to be completed. What should we do?

Through communication with leaders and discussions among colleagues, we finally feel that only by refining the existing market and developing new markets can we increase sales. Large hospitals will develop departments that can be used in place, health centers will lay out all the following service stations in place, and newly developed customers will be trained quietly to become VIP. At the same time to develop ophthalmology, increase the sales of new products, walk on two legs, take every step seriously.

Sales is a good training in life. If you want to do a good job in sales, I personally think you must have a high comprehensive ability and learning ability. At ordinary times, we should be diligent in thinking about working methods and skills and expand our thinking. We should be optimistic and positive to face the problems in our work. Work enthusiastically.

2020

has passed, and the 2021 is coming soon. The new year has a new goal. As long as we work hard and focus on optimism, I believe the sales volume will definitely get better and better.

Xu Zihan

sales work, both ups and downs, thank the company very much, let me get exercise in recent years.

The most important thing is to learn carefully and serve customers attentively. When visiting the hospital, I will pay more attention to observation. Sometimes I find that they often look everywhere for the same thing. I will help take it there next time. This is a trivial matter for me. When I think about it, I will do it. However, the teachers in the hospital will think that I am very careful and trustworthy. At ordinary times, I will send more messages to customers when I am free. Some words cannot be expressed in words. It will be better to express them in words. Holiday greetings and a message may have unexpected results. Just like Christmas, I sent a message to all my customers. Although only 30% of them gave me a message back, I was satisfied.

In the past few years of work, I have experienced losses, regrets, and gains and enrichment... For the new year, I still have dreams in my heart. If the policy allows, Les has to be able to Get better and better, and other products can be made slowly. In the new year, I hope that with the support of the leadership, we can go to the next level, not be at a loss for the current difficulties, and believe that our efforts can create a brilliant tomorrow.

Zheng Jie

Looking back on 2020, I experienced epidemic situation, drug withdrawal, limited amount and other events, and I felt a lot of emotion in my heart.

In particular, the implementation of amlodipine band procurement in 2020, under the impact of the primary completion of hospitals with similar varieties of band volume, coupled with the new crown epidemic led to the national home epidemic prevention, the sales of Rest has dropped sharply, and some hospitals even stopped the procurement of Rest first. However, I still maintain a high frequency of contact with customers, learned that they are in the front line of the epidemic, a mask to use two days, I began to trust various relationships to buy masks, masks sent to the hands of doctors, to do something to fight the epidemic. When doctors received masks, they laughed and said they were the most useful gift in life. I also participated in the volunteer service of the hospital, and went door-to-door with them to fill in the personnel information form. Through such efforts, I finally got the praise of the hospital leaders and restored the prescription of Ristek.

June is the time to fill in the volunteer form for the college entrance examination. The hospital I maintain has 12 doctors' children who need to fill in the volunteer form. Usually, I pay more attention to the details of voluntary reporting. When I provide them with accurate and reasonable suggestions, I suddenly become their voluntary reporting consultant. I used the rest time to communicate with the examinees. According to their thoughts, learning ability and personality, I constantly revised dozens of filling plans. From the choice of school and major to the ranking of school volunteers, I gave reasonable suggestions. When their children received the admission notice of their favorite school, the trust of customers in me increased to a higher level, at the same time, it also completed the conversion from business to friends, to enhance their loyalty to the company's varieties. First of all, do a good job of people and get their recognition, and they will transfer this recognition to the product, which will turn into support for my work.

More information

Yunnan peak through the safety standard secondary acceptance

On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate

2020

07-30

Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory

News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Accident-free factory creation enters "second season"

At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open

2020

07-31

What will the Chinese Medicine Act bring us?

At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.

2020

07-31

< 1...49 50 51...61 > 跳转到页